Coronavirus: UK herd immunity ‘may be closer than thought’
New study finds that antibody tests may be failing to identify large numbers of people who have been exposed to Covid-19
Many more people than previously thought are likely to have Covid-19 antibodies, according to new research that suggests the UK may be closer to herd immunity than previously thought.
“Current antibody tests fail to identify people who had mild infections,” scientists write in a newly published paper in the British Medical Journal.
One of the team behind the research, Dr Stephen Burgess of Cambridge University, says that widely used tests are also highly selective in what they can detect.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
“It’s possible that somebody could have antibodies present in their saliva but not in their blood and it’s possible that somebody could have one class of antibody but not another class of antibodies,” he told The Times.
“This might explain why, in cities such as London, we have seen the breakdown of widespread social distancing but infection rates have still not increased sharply.”
Random antibody testing suggests that 17% of Londoners and 5% of people across the UK have an immune response to the virus. But these figures refer only to bloodborne IgG and IgM antibodies, and not the IgA antibodies found in the mouth, eyes and nose, the new study paper says.
“IgA also has an important role in the immune response to respiratory tract infections and seems immunologically relevant in Covid-19, particularly in asymptomatic people,” the researchers report.
According to the scientists, 15% of UK health workers with negative results from standard antibody tests are found to have IgA antibodies. And in Luxembourg, IgA antibodies have been found in five times as many people as have IgG antibodies.
Many experts believe that at least 70% of the population would need to be exposed to the coronavirus before it would naturally stop spreading - resulting in large numbers of deaths.
But others, including Oxford University theoretical epidemiologist Sunetra Gupta, have suggested the figure could be more like 20%, owing to partial immunity resulting from exposure to related viruses.
“Her views have split the scientific community,” says ITV News. “While few disagree with the theory, they argue we don’t know enough to be sure that stepping back and allowing immunity to develop will work in practice.”
Burgess says that some scientists are reluctant to question the received wisdom about the prevalence of antibodies.
“We’ve been asking ourselves the question of why this has not got more attention,” he told The Times. “It is clearly very important to our understanding of the disease.
“I think scientists are cautious, and would prefer to say nothing if they are not sure, even when saying nothing also has consequences.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Holden Frith is The Week’s digital director. He also makes regular appearances on “The Week Unwrapped”, speaking about subjects as diverse as vaccine development and bionic bomb-sniffing locusts. He joined The Week in 2013, spending five years editing the magazine’s website. Before that, he was deputy digital editor at The Sunday Times. He has also been TheTimes.co.uk’s technology editor and the launch editor of Wired magazine’s UK website. Holden has worked in journalism for nearly two decades, having started his professional career while completing an English literature degree at Cambridge University. He followed that with a master’s degree in journalism from Northwestern University in Chicago. A keen photographer, he also writes travel features whenever he gets the chance.
-
Does Trump have the power to end birthright citizenship?
Today's Big Question He couldn't do so easily, but it may be a battle he considers worth waging
By Joel Mathis, The Week US Published
-
2024: the year of romantasies
In the Spotlight A generation of readers that grew up on YA fantasy series are getting their kicks from the spicy subgenre
By Theara Coleman, The Week US Published
-
US won its war on 'murder hornets,' officials say
Speed Read The announcement comes five years after the hornets were first spotted in the US
By Peter Weber, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published